GLP-1 Therapies Show Promise for Alzheimer’s Prevention
GLP-1 receptor agonists show promise in Alzheimer’s disease prevention, offering benefits beyond weight loss and diabetes management.
GLP-1 receptor agonists show promise in Alzheimer’s disease prevention, offering benefits beyond weight loss and diabetes management.
Explore top insights from A4M’s Longevity Conference, including neurotransmitter health, vagus nerve stimulation, GLP-1 therapy, and cellular longevity.
Research review: how a two-week social media detox can reduce stress, improve sleep, and foster healthier habits.